ArticleJournal of thoracic disease2026

Clarifying the role of flumonertinib rechallenge in EGFR-mutated non-small cell lung cancer.

Haoyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.